Grit Bio
沙砾生物GRIT Biotechnology是一家聚焦世界尖端生物科技，专注于肿瘤免疫治疗领域的高科技创新企业。
China · Founded 2019 · $75.3M raised
- Founded
- 2019
- Website
- grit-bio.com
- Total Funding
- $75.3M
- Last Round
- $60.0M Series BSep 2023
- Rounds
- 2
About
Clinical-stage Chinese biotech developing tumor-infiltrating lymphocyte therapy for cancers.
Summary
Grit Bio is a Biotech company based in China, founded in 2019. It has raised $75.3M in total across 2 rounds, most recently a $60.0M Series B round in Sep 2023. Investors include CICC and B Capital Group.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company